LYEL
Lyell Immunopharma Inc
9.30$
-1.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 73.8% | 74.0% | 76.9% | 76.4% | 72.7% | 77.3% | 71.9% | 73.2% | 80.4% | 76.7% | 76.2% | 68.6% | |
| 36.0% | 19.4% | 18.1% | 20.4% | 16.2% | 21.5% | 28.0% | 25.6% | 30.3% | 17.7% | 25.9% | 23.5% | |
| 72.4% | 72.8% | 75.8% | 75.1% | 71.1% | 75.5% | 70.1% | 71.8% | 78.3% | 72.7% | 72.4% | 65.6% | |
| 12.3% | 12.7% | 13.1% | 13.4% | 14.3% | 22.0% | 21.7% | 22.4% | 19.3% | 27.0% | 21.9% | 24.9% | |
| 4.4% | 4.6% | 4.7% | 4.7% | 5.4% | 11.0% | 9.6% | 9.6% | 7.8% | 14.5% | 10.5% | 12.8% | |
| 0.8% | 0.8% | 1.0% | 1.1% | 1.2% | 1.6% | 1.9% | 2.2% | 2.2% | 2.7% | 2.7% | – | |
| 0.5% | 0.6% | 0.7% | 0.6% | 0.6% | 1.1% | 0.9% | 0.9% | 0.6% | 0.9% | 1.6% | 1.2% | |
| 87.7% | 87.3% | 86.9% | 86.6% | 85.7% | 78.0% | 78.3% | 77.6% | 80.7% | 73.0% | 78.1% | 75.1% | |
| -119.4% | -133.6% | -153.1% | -169.5% | -186.2% | -274.0% | -325.1% | -373.6% | -362.5% | -476.3% | -468.8% | -542.6% | |
| 1.6% | 1.7% | 1.8% | 2.0% | 2.1% | 2.7% | 3.4% | 3.8% | 4.5% | 5.0% | 6.2% | 7.5% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.